$ASCLETIS-B (01672.HK)$announced in partnership with Sagimet Biosciences Inc. The first patient in its Phase IIb non-alcoholic steatohepatitis (NASH) clinical trial (fascinate-2) has been administered.
1
1
Report
cheez_lit
:
great to see that medicine in the world continues to improve
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Anivid : over priced...